Toujeo Solostar 300 Unit/mL Solution Pen-Injector How to Use: A Step-by-Step Clinical Guide

The Toujeo Solostar 300 unit/mL pen-injector is used by injecting the prescribed dose under the skin of the abdomen, thigh, or upper arm once daily, using a new needle for each injection and priming the pen with 3 units before the first use and with 2 units before each subsequent injection. The pen delivers insulin glargine at three times the concentration of standard U-100 basal insulin, so the dose dials in single units but the liquid volume is smaller. Read the full technique below before your first injection.

The 300 unit/mL concentration changes volume, not the dial

Toujeo contains insulin glargine at 300 units per milliliter, compared with 100 units per milliliter in standard U-100 glargine. The pen's dose dial is calibrated in units, so what you see on the dial is the dose you inject. What changes is the physical volume: a 30-unit dose occupies 0.1 mL in a Toujeo pen but 0.3 mL in a U-100 pen. This is why the pen is sometimes called concentrated, and why the same dial number does not mean the same volume across products.

The clinical reason for the higher concentration is not to make the insulin stronger per unit. One unit of insulin glargine is one unit regardless of concentration. The 300 unit/mL formulation produces a smaller subcutaneous depot after injection, and that smaller depot releases insulin more slowly and over a longer window than the U-100 form. The practical result is a flatter, longer profile in many patients, which is why Toujeo is often chosen when fasting glucose drifts overnight on other basal insulins.

The pen itself is a prefilled, disposable device with a 3 mL cartridge. That cartridge holds 900 units at 300 unit/mL. A dose dial of 1 to 80 units is available per injection on the Solostar pen, and the dial clicks in single-unit increments. The maximum single injection is 80 units; doses above that require a second injection or a different delivery method.

A plain-language version: the pen is just a syringe with a dial, and the dial counts insulin units, not milliliters. Trust the dial number your prescriber gave you.

Quantified context: what the numbers actually mean

The 3 mL cartridge at 300 unit/mL holds 900 units, which is three times the unit count of a 3 mL U-100 cartridge. At a typical basal dose of 20 to 40 units per day, one pen lasts roughly 22 to 45 days of injections, though the product's in-use dating rules determine when an opened pen must be discarded.

The dial's 80-unit maximum matters for high-dose patients. A patient on 100 units daily cannot deliver that in one dial turn and must split the dose into two injections at separate sites, or use a different pen or vial. This is a real constraint, not a rounding detail.

The priming step is quantified: 3 units before the first injection after a new pen is opened, and 2 units before every subsequent injection. That priming volume expels air from the needle and confirms the dial and needle are flowing. It is not part of the dose.

The 300 unit/mL concentration also means a smaller injection volume per unit. A 60-unit dose is 0.2 mL at 300 unit/mL versus 0.6 mL at 100 unit/mL. Smaller volume can matter for patients with lipohypertrophy or limited injection sites, though it does not change the insulin's biological effect per unit.

There is no validated bedside conversion factor between Toujeo and U-100 glargine that you should apply yourself. Switching between concentrations is a prescriber decision, and the dose is usually not a simple 1:1 swap. Do not convert on your own.

Timeline: what happens during and after an injection

The timeline table is qualitative because insulin glargine's profile is well described in general terms but individual absorption varies. The 300 unit/mL form is associated with a longer, flatter profile than U-100 glargine in product labeling, but the exact hours are patient-specific and should not be treated as fixed.

Edge cases that change the technique

Lipohypertrophy is the most underappreciated edge case. Repeated injections into the same spot cause fatty lumps that absorb insulin unpredictably. Rotate at least 1 cm from the last site and inspect sites regularly. A lumpy site can make a stable dose behave like a variable dose.

Needle length and skin fold matter. For most adults, a 4 mm pen needle injected at 90 degrees into a lifted skin fold is appropriate. Thinner patients and children may need a skin fold; obese patients may not. The prescriber or diabetes educator should confirm technique for your body type.

Missed doses are common. If a once-daily basal dose is missed, the general guidance is to take it when remembered unless it is close to the next scheduled dose, at which point skipping is safer than stacking. Confirm with your prescriber, because stacking basal insulin can cause prolonged hypoglycemia.

Storage changes the pen's behavior. An in-use pen is typically kept at room temperature for a labeled number of days; a pen that has been frozen or overheated may deliver unreliable doses. Do not use a pen that has been frozen, and do not store an in-use pen in a refrigerator if the label says room temperature.

Misconceptions worth correcting

The most common misconception is that 300 unit/mL means "three times stronger" per unit. It does not. One unit is one unit. The concentration changes volume and release profile, not the unit definition.

A second misconception is that the dial number is a volume. It is not. The dial counts units. A patient who reads "0.3 mL" on another pen and tries to match it on a Toujeo dial will be badly wrong.

A third misconception is that priming is optional. Air in the needle means a partial dose, and a partial basal dose can be invisible until fasting glucose rises days later. Prime every time.

A counterintuitive professional caveat: a smaller injection volume does not automatically mean less discomfort or better absorption. The 300 unit/mL depot is smaller, but the tissue response and the patient's site rotation habits still dominate. Technique beats concentration.

Practical actions before and during each injection

Wash hands and inspect the pen for cloudiness, clumps, or discoloration; do not use a pen that looks abnormal. Attach a new pen needle and prime with 3 units for a new pen or 2 units for a pen already in use. Dial the prescribed dose and confirm the number before injecting; the dial clicks in single units. Inject into the abdomen, thigh, or upper arm at a 90-degree angle, holding the needle in place for the labeled seconds before withdrawing. Rotate sites at least 1 cm each time and inspect for lumps before choosing a site. Record the dose and the site; bring the pen and log to appointments for technique review.

Red-flag warnings:

Do not share a pen or needle with another person, even after changing the needle; bloodborne contamination is possible. Do not inject a dose you cannot confirm on the dial; a misread dial is a dosing error. Do not use a pen that has been frozen, dropped with the cartridge damaged, or exposed to extreme heat. Do not stack a missed basal dose without prescriber guidance; overlapping basal insulin can cause prolonged hypoglycemia. Seek urgent care for severe hypoglycemia with confusion, seizure, or loss of consciousness.

Comparison with alternatives

The comparison is qualitative because product labeling and availability change. Confirm the current labeling and the pen's dial maximum with your pharmacist before relying on any comparison.

Limitations of this guide

This guide describes general technique and mechanism, not a personal dosing plan. The dose, the titration schedule, and the choice of basal insulin are prescriber decisions. Product labeling, pen design, and in-use storage rules can change; the current package insert and your pharmacist are the authority on the specific pen in your hand. Individual absorption, hypoglycemia risk, and site response vary, so technique should be reviewed with a diabetes educator when possible.

This article is general educational information, not a diagnosis or treatment plan. It does not promise any outcome and does not replace the instructions from your prescriber or the current package insert. For dosing decisions, hypoglycemia management, or injection technique specific to your body, consult a qualified local clinician or pharmacist.